Your browser doesn't support javascript.
loading
Reply to Zhu et al.: Implications of CHRNB1 and ERBB2 in the pathobiology of myasthenia gravis.
Chia, Ruth; Saez-Atienzar, Sara; Drachman, Daniel B; Traynor, Bryan J.
Affiliation
  • Chia R; Neuromuscular Diseases Research Section, Laboratory of Neurogenetics, National Institute on Aging, Bethesda, MD 20892.
  • Saez-Atienzar S; Neuromuscular Diseases Research Section, Laboratory of Neurogenetics, National Institute on Aging, Bethesda, MD 20892.
  • Drachman DB; Department of Neurology, Johns Hopkins School of Medicine, Baltimore, MD 21287.
  • Traynor BJ; Neuromuscular Diseases Research Section, Laboratory of Neurogenetics, National Institute on Aging, Bethesda, MD 20892.
Proc Natl Acad Sci U S A ; 119(36): e2209096119, 2022 09 09.
Article in En | MEDLINE | ID: mdl-35969799
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptors, Nicotinic / Receptor, ErbB-2 / Myasthenia Gravis Limits: Humans Language: En Journal: Proc Natl Acad Sci U S A Year: 2022 Document type: Article Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptors, Nicotinic / Receptor, ErbB-2 / Myasthenia Gravis Limits: Humans Language: En Journal: Proc Natl Acad Sci U S A Year: 2022 Document type: Article Country of publication: United States